Pedro Almagro1, Joan B Soriano2, Francisco J Cabrera3, Ramon Boixeda4, M Belen Alonso-Ortiz5, Bienvenido Barreiro6, Jesus Diez-Manglano7, Cristina Murio8, Josep L Heredia6. 1. Internal Medicine Service, Hospital Universitario Mutua De Terrassa, Universidad de Barcelona, Barcelona. Electronic address: 19908pam@comb.cat. 2. Programa de Epidemiología e Investigación Clínica, Fundación Caubet-Cimera, Centro Internacional de Medicina Respiratoria Avanzada, Baleares. 3. Internal Medicine Service, Hospital General Universitario Gregorio Marañón, Madrid. 4. Internal Medicine Service, Hospital de Mataró, Barcelona. 5. Internal Medicine Service, Hospital Juan Negrín, Gran Canaria. 6. Respiratory Service, Hospital Universitario Mutua De Terrassa, Universidad de Barcelona, Barcelona. 7. Internal Medicine Service, Hospital Royo Villanova, Zaragoza, Spain. 8. Medical Department, Laboratorios Chiesi, Barcelona.
Abstract
BACKGROUND: No valid tools exist for evaluating the prognosis in the short and medium term after hospital discharge of patients with COPD. Our hypothesis was that a new index based on the CODEX (comorbidity, obstruction, dyspnea, and previous severe exacerbations) index can accurately predict mortality, hospital readmission, and their combination for the period from 3 months to 1 year after discharge in patients hospitalized for COPD. METHODS: A multicenter study of patients hospitalized for COPD exacerbations was used to develop the CODEX index, and a different patient cohort was used for validation. Comorbidity was measured using the age-adjusted Charlson index, whereas dyspnea, obstruction, and severe exacerbations were calculated according to BODEX (BMI, airfl ow obstruction, dyspnea, and previous severe exacerbations) thresholds. Information about mortality and readmissions for COPD or other causes was collected at 3 and 12 months after hospital discharge. RESULTS: Two sets of 606 and 377 patients were included in the development and validation cohorts, respectively. The CODEX index was associated with mortality at 3 months ( P < .0001; hazard ratio [HR], 1.5; 95% CI, 1.2-1.8) and 1 year ( P < .0001; HR, 1.3; 95% CI, 1.2-1.5 ), hospital readmissions in the same periods, and their combination (all P < .0001). All CODEX C statistics were superior to those of the BODEX, DOSE (dyspnea, airfl ow obstruction, smoking status, and exacerbation frequency), and updated ADO (age, dyspnea, and airfl ow obstruction) indexes. CONCLUSIONS: The CODEX index was a useful predictor of survival and readmission at both 3 months and 1 year after hospital discharge for a COPD exacerbation, with a prognostic capacity superior to other previously published indexes.
BACKGROUND: No valid tools exist for evaluating the prognosis in the short and medium term after hospital discharge of patients with COPD. Our hypothesis was that a new index based on the CODEX (comorbidity, obstruction, dyspnea, and previous severe exacerbations) index can accurately predict mortality, hospital readmission, and their combination for the period from 3 months to 1 year after discharge in patients hospitalized for COPD. METHODS: A multicenter study of patients hospitalized for COPD exacerbations was used to develop the CODEX index, and a different patient cohort was used for validation. Comorbidity was measured using the age-adjusted Charlson index, whereas dyspnea, obstruction, and severe exacerbations were calculated according to BODEX (BMI, airfl ow obstruction, dyspnea, and previous severe exacerbations) thresholds. Information about mortality and readmissions for COPD or other causes was collected at 3 and 12 months after hospital discharge. RESULTS: Two sets of 606 and 377 patients were included in the development and validation cohorts, respectively. The CODEX index was associated with mortality at 3 months ( P < .0001; hazard ratio [HR], 1.5; 95% CI, 1.2-1.8) and 1 year ( P < .0001; HR, 1.3; 95% CI, 1.2-1.5 ), hospital readmissions in the same periods, and their combination (all P < .0001). All CODEX C statistics were superior to those of the BODEX, DOSE (dyspnea, airfl ow obstruction, smoking status, and exacerbation frequency), and updated ADO (age, dyspnea, and airfl ow obstruction) indexes. CONCLUSIONS: The CODEX index was a useful predictor of survival and readmission at both 3 months and 1 year after hospital discharge for a COPD exacerbation, with a prognostic capacity superior to other previously published indexes.
Authors: Ian G Stiell; Jeffrey J Perry; Catherine M Clement; Robert J Brison; Brian H Rowe; Shawn D Aaron; Andrew D McRae; Bjug Borgundvaag; Lisa A Calder; Alan J Forster; Jennifer Brinkhurst; George A Wells Journal: CMAJ Date: 2018-12-03 Impact factor: 8.262
Authors: Jakob I McSparron; Margaret M Hayes; Jason T Poston; Carey C Thomson; Henry E Fessler; Renee D Stapleton; W Graham Carlos; Laura Hinkle; Kathleen Liu; Stephanie Shieh; Alyan Ali; Angela Rogers; Nirav G Shah; Donald Slack; Bhakti Patel; Krysta Wolfe; William D Schweickert; Rita N Bakhru; Stephanie Shin; Rebecca E Sell; Andrew M Luks Journal: Ann Am Thorac Soc Date: 2016-05
Authors: Cristóbal Esteban; Ady Castro-Acosta; Carlos Jose Alvarez-Martínez; Alberto Capelastegui; José Luis López-Campos; Francisco Pozo-Rodriguez Journal: BMC Pulm Med Date: 2018-01-25 Impact factor: 3.317
Authors: Maxine Whelan; Christopher Biggs; Carlos Areia; Elizabeth King; Beth Lawson; Nikki Newhouse; Xiaorong Ding; Carmelo Velardo; Mona Bafadhel; Lionel Tarassenko; Peter Watkinson; David Clifton; Andrew Farmer Journal: Digit Health Date: 2021-05-27
Authors: Björn Ställberg; Karin Lisspers; Kjell Larsson; Christer Janson; Mario Müller; Mateusz Łuczko; Bine Kjøller Bjerregaard; Gerald Bacher; Björn Holzhauer; Pankaj Goyal; Gunnar Johansson Journal: Int J Chron Obstruct Pulmon Dis Date: 2021-03-16